RxDoctor Payments Data

Micah Shuler

Psychiatric/Mental Health · Sherman, TXNPI 1760031330

Payments from drug & device makers

$2,507in general payments, 2019–2025

Across 173 payments — averaging $14.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$592
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$334
  • Sunovion Pharmaceuticals Inc.$323
  • Johnson & Johnson$200
  • Avanir Pharmaceuticals, Inc.$188
  • Lundbeck LLC$184
  • plus $687 from 10 others

What the payments were for

  • Food & beverage$2,46098%
  • Education$472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,507 in reported general payments places this provider in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate29$75,012
VraylarCariprazine Hcl43$54,555
RexultiBrexpiprazole12$17,676
Risperdal ConstaRisperidone Microspheres23$7,198
BelsomraSuvorexant11$4,519
Quetiapine Fumarate93$2,218
Aripiprazole29$1,768
Vilazodone Hcl17$1,197
Trazodone Hcl126$1,116
Lamotrigine105$1,105
Doxepin Hcl41$1,080
Bupropion XlBupropion Hcl44$1,054
Haloperidol13$1,042
Ziprasidone Hcl23$1,017
Fluvoxamine Maleate11$922

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$200$82,20952 claims
AbbVieVraylar$592$54,55543 claims
Otsuka America Pharmaceutical, Inc.Rexulti$144$17,67612 claims
Almatica Pharma LLCSertraline Hcl$71$31543 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Sherman

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →